Loading...

Loading...

Global Trials Will Test AI-Engineered Antibody for Severe Asthma
Global Trials Will Test AI-Engineered Antibody for Severe Asthma
By MBN Staff - Mon, 12/01/2025 - 17:37
Therapeutics company Generate:Biomedicines will begin global Phase 3 trials of GB-0895, an AI-designed antibody for severe asthma.

Featured content

Most popular

Partnership Content

Cluster Automotriz Nuevo Leon
https://mexicobusiness.news/tag/severe-asthma
More Health
GSK's Depemokimab Shows Promise for Severe Asthma Treatment
GSK's Depemokimab Shows Promise for Severe Asthma Treatment
By Anmol Motwani - Fri, 05/24/2024 - 11:13
GSK's Depemokimab,, a six-month dosing schedule, reduces severe asthma attacks in high eosinophil patients, marking a milestone in respiratory health.